Prevalence of clinical remission in patients with sporadic idiopathic hypoparathyroidism

被引:10
作者
Goswami, Ravinder [1 ]
Goel, Siya [1 ]
Tomar, Neeraj [1 ]
Gupta, Nandita [1 ]
Lumb, Vanshika [2 ]
Sharma, Yagya Dutta [2 ]
机构
[1] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India
关键词
CALCIUM-SENSING RECEPTOR; GRAVES-DISEASE; AUTOANTIBODIES; PARATHYROIDITIS; ANTIBODIES; TYPE-1; CELL;
D O I
10.1111/j.1365-2265.2009.03653.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background Remission of disease activity is a characteristic feature of autoimmune endocrine disorders such as Graves' disease, Addison's disease and occasionally in patients with premature ovarian failure. Autoimmunity is also implicated in sporadic idiopathic hypoparathyroidism (SIH) with clinical remission of disease reported in three cases. Objective To assess the rate of remission in patients with sporadic idiopathic hypoparathyroidism and review the cases reported so far. Subjects and methods Subjects included 53 patients (M:F, 24:29) with SIH who had been symptomatic for at least 1 year (range 1-31 years). They were treated with calcium and 1-alpha-(OH)D-3/cholecalciferol therapy and had a mean duration of follow up of 5 center dot 0 +/- 3 center dot 2 years. Treatment was withdrawn in two stages in the patients who maintained normal levels of serum total calcium during the preceding year of treatment. In stage-1, the dose of therapy was reduced to half and subsequently all treatment was stopped (stage 2) in those patients who maintained normal serum total calcium levels on the reduced dose. Remission of SIH was defined as maintenance of normal serum total (>= 2 center dot 12 mmol/l) and ionized calcium, inorganic phosphorus and serum intact parathyroid hormone (iPTH) for at least 3 months after withdrawal of calcium and 1-alpha-(OH)D-3/cholecalciferol therapy. Calcium sensing receptor autoantibodies (CaSRAb) were determined by Western blot. Results Two of the 53 patients (3 center dot 8%) with SIH stayed in remission for 1 year after complete withdrawal of therapy. CaSRAb was absent in both the cases. The clinical features, age at onset and duration of hypocalcaemic symptoms in cases with remission were comparable to those who did no show remission. Conclusion Sporadic idiopathic hypoparathyroidism is not irreversible as is widely believed and spontaneous remission of disease may occur in 3 center dot 8% of patients.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 29 条
[1]   Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy [J].
Ahrens, W ;
Hiort, O ;
Staedt, P ;
Kirschner, T ;
Marschke, C ;
Kruse, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4630-4634
[2]   Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen [J].
Alimohammadi, Mohammad ;
Bjorklund, Peyman ;
Hallgren, Asa ;
Pontynen, Nora ;
Szinnai, Gabor ;
Shikama, Noriko ;
Keller, Marcel P. ;
Ekwall, Olov ;
Kinkel, Sarah A. ;
Husebye, Eystein S. ;
Gustafsson, Jan ;
Rorsman, Fredrik ;
Peltonen, Leena ;
Betterle, Corrado ;
Perheentupa, Jaakko ;
Akerstrom, Goran ;
Westin, Gunnar ;
Scott, Hamish S. ;
Hollaender, Georg A. ;
Kampe, Olle .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (10) :1018-1028
[3]   Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study [J].
Benker, G ;
Reinwein, D ;
Kahaly, G ;
Tegler, L ;
Alexander, WD ;
Fassbinder, J ;
Hirche, H .
CLINICAL ENDOCRINOLOGY, 1998, 49 (04) :451-457
[4]  
Blizzard R M, 1966, Clin Exp Immunol, V1, P119
[5]   HYPERPLASTIC PARATHYROIDITIS - A NEW AUTOIMMUNE-DISEASE [J].
BOYCE, BF ;
DOHERTY, VR ;
MORTIMER, G .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (08) :812-814
[6]   REMISSION OF SUBCLINICAL ADRENOCORTICAL FAILURE IN SUBJECTS WITH ADRENAL AUTOANTIBODIES [J].
DEBELLIS, A ;
BIZZARRO, A ;
ROSSI, R ;
PAGLIONICO, VA ;
CRISCUOLO, T ;
LOMBARDI, G ;
BELLASTELLA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04) :1002-1007
[7]  
Dogra Sunil, 2005, Dermatol Online J, V11, P30
[8]  
DOWNS RW, 2001, PARATHYROID BASICS C, P755
[9]   Proton-pump inhibitors and hypomagnesemic hypoparathyroidism [J].
Epstein, Martin ;
McGrath, Shaun ;
Law, Florence .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1834-1836
[10]   Primary hyperparathyroidism presumably caused by chronic parathyroiditis manifesting from hypocalcemia to severe hypercalcemia [J].
Furuto-Kato, S ;
Matsukura, S ;
Ogata, M ;
Azuma, N ;
Manabe, T ;
Shigeno, C ;
Asato, R ;
Tanaka, K ;
Komatsu, Y ;
Nakao, K .
INTERNAL MEDICINE, 2005, 44 (01) :60-64